By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Genocea Biosciences 

161 1st Street
Suite 2C
Cambridge  Massachusetts    U.S.A.
Phone: 617-876-8191 Fax: 617-500-0969



Start Up

Company News
Genocea Biosciences Presents Complete Phase 1/2a Data For HSV-2 Immunotherapy At IDWeek 10/8/2014 7:48:41 AM
Genocea Biosciences Announces $1.2 Million Grant For Malaria Vaccine Discovery 9/23/2014 10:41:39 AM
Genocea Biosciences To Present At The 21st Annual NewsMakers In The Biotech Industry Conference 9/19/2014 8:26:44 AM
Virology Publishes Genocea Biosciences HSV-2 Antigen Discovery Paper 9/16/2014 8:30:01 AM
Genocea Biosciences Commences Phase 2a Trial For GEN-004, Universal Pneumococcal Vaccine Candidate 9/12/2014 11:00:08 AM
Genocea Biosciences Appoints Kenneth Bate To Its Board of Directors 9/11/2014 11:46:25 AM
Genocea Biosciences Presents Phase 1 Immunology Data For Novel Pneumoccocus Vaccine At ICAAC 9/8/2014 11:34:46 AM
Genocea Biosciences Reports Second Quarter 2014 Financial Results 8/6/2014 9:36:59 AM
Genocea Biosciences To Announce Second Quarter 2014 Financial Results On August 6, 2014 7/30/2014 10:51:38 AM
Genocea Biosciences HSV-2 Immunotherapeutic GEN-003 Elicits Significant, Durable T Cell Responses In Vaccinated Subjects 7/22/2014 11:22:33 AM